When Goldman Sachs buys Neos Investments, it’ll acquire products testing how decades-old laws are applied to a new generation of tax-optimizing strategies.
After Pfizer’s venture arm co-led Enodia Therapeutics’ $25 million seed round in January, the pharma has signed up to collaborate with the biotech on small-molecule drugs to eliminate pathogenic proteins where they’re being made.
Bellwether Johnson & Johnson will kick off the third quarter earnings reporting period on Tuesday, with analysts searching for news on business development, launch execution and more.
Only 24% of organizations maintain CPA-only requirements, while the rest are automating, broadening to nontraditional backgrounds or sourcing talent externally.
Chris Puglia, recently appointed Deloitte Tax’s very first chief product officer, said he aims to bring a product mindset to the Big Four firm’s service delivery model with an eye towards driving further commercialization.